Charles River Laboratories International, Inc. (CRL) NYSE
174.79
-7.28(-4.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.09B |
| Enterprise Value | 12.95B |
| P/E Ratio | -46.34 |
| PEG Ratio | 0.46 |
| Price/Sales Ratio | 2.09 |
| Price/Book Ratio | 2.91 |
| Enterprise/Revenue | 2.8 |
| Enterprise/EBITDA | 14.03 |
Fiscal Year
| Fiscal Year | December 27, 2025 |
| Most Recent Quarter | March 28, 2026 |
Profitability
| Profit Margin | -0.05 |
| Operating Margin | 0.12 |
Management Effectiveness
| Return On Assets | -0.02 |
| Return On Equity | -0.06 |
Income Statement
| Revenue | 4.02B |
| Revenue/Share | 82.27 |
| Gross Profit | 1.23B |
| EBITDA | 911.15M |
| Net Income | -144.34M |
| Diluted EPS | -2.91 |
Balance Sheet
| Total Cash | 191.83M |
| Total Cash/Share | 3.92 |
| Total Debt | 3.06B |
| Total Debt/Equity | 1.04 |
| Current Ratio | 1.36 |
| Book Value Per Share | 61.05 |
Price History
| 52-Week Change | 29.44 |
| 52-Week High | 228.88 |
| 52-Week Low | 132.65 |
| Moving Average 50 Days | 169.64 |
| Moving Average 200 Days | 176.42 |
Statistics
| Average Volume | 901,147 |
| Shares Outstanding | 48.17M |
| % Held by Institutions | 116.03 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
